Vanguard realigns reporting; subsidiaries to report TXG holdings (TXG)

Rhea-AI Filing Summary

10X Genomics Inc Schedule 13G/A amendment shows The Vanguard Group reporting zero shares beneficially owned of Common Stock after an internal realignment effective January 12, 2026. The filing states Vanguard's subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.

The filing records 0 shares beneficially owned and 0% of the class, with no sole or shared voting or dispositive power listed. The signature block is by Ashley Grim, Head of Global Fund Administration dated 03/25/2026.

Insights

Institutional Ownership Analyst

Vanguard disaggregated holdings; reports zero beneficial ownership here.

The amendment states that on January 12, 2026 Vanguard reorganized and certain subsidiaries now report separately under SEC Release No. 34-39538. The filing lists 0 shares and 0% beneficial ownership for The Vanguard Group on the reported class.

Practical effect: this entry documents an administrative change in reporting structure rather than an economic divestiture; subsequent 13G/A entries from Vanguard affiliates may show holdings in other filings.

Corporate Governance Specialist

administrative reallocation of reporting responsibility, not a statement about overall investment exposure.

The amendment cites disaggregation of previously aggregated beneficial ownership to subsidiary-level reporters in reliance on the specified SEC release. The signature attests to the procedural change; cash‑flow treatment or proceeds are not addressed in the excerpt.

Investors should expect related filings from Vanguard affiliates; timing and amounts for those filings are not provided in this excerpt.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

10X Genomics Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

(CUSIP Number)

03/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: 10X Genomics Inc
(b)	Address of issuer's principal executive offices: 6230 Stoneridge Mall Road, Pleasanton, CA, 94566
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd.,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	03/25/2026

FAQ

What does Vanguard's Schedule 13G/A amendment for TXG state?

It states The Vanguard Group reports 0 shares and 0% beneficial ownership after an internal realignment on January 12, 2026. The filing cites SEC Release No. 34-39538 and is signed 03/25/2026.

Does this filing mean Vanguard sold all TXG shares?

No. The amendment explains an internal realignment and disaggregation of reporting; it does not state sales or transfers. The filing shows 0 shares reported by The Vanguard Group entity.

Which SEC guidance does the filing reference and why is it relevant?

The filing references SEC Release No. 34-39538, which permits disaggregated reporting by subsidiaries. Vanguard cites it to explain that subsidiaries will report holdings separately after the realignment.

Who signed the Schedule 13G/A amendment for Vanguard?

The filing is signed by Ashley Grim, titled Head of Global Fund Administration, with the signature date 03/25/2026, attesting to the amendment's statements.

Will other Vanguard-related filings show TXG ownership?

Possibly. The amendment states subsidiaries will report separately under the SEC release, so related Vanguard affiliates may file their own Schedule 13G/A or 13D forms showing holdings.